Patents
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
07/2002
07/04/2002WO2002012274A3 Iapl-3 a protein inhibitor of apoptosis proteins
07/04/2002WO2002002624A3 B7-like molecules and uses thereof
07/04/2002WO2001094400A3 A GENE ENCODING A MULTIDRUG RESISTANCE HUMAN P-GLYCOPROTEIN HOMOLOGUE ON CHROMOSOME 7p15-21 AND USES THEREOF
07/04/2002WO2001092492A3 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
07/04/2002WO2001090148A8 Neurotransmitter transporters
07/04/2002WO2001083515A3 Simulated activity of protein a displayed by ligands attached to a cellulose bead surface
07/04/2002WO2001081414A3 Integrin alpha subunit and uses thereof
07/04/2002WO2001079481A3 Methods of constructing display libraries of genetic packages for members of a diverse family of peptides
07/04/2002WO2001078779A3 Antibody alpha4beta7 integrin and its use to treat inflammatory bowel disease
07/04/2002WO2001078768A3 Targeted vaccine delivery systems
07/04/2002WO2001077169A3 Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides
07/04/2002WO2001070266A3 Method of inhibiting stenosis and restenosis with a mixture of antibodies anti cd18 and anti ccr2
07/04/2002WO2001068855A3 Gtp-binding protein gamma-12 subunit
07/04/2002WO2001055364A3 Nucleic acids, proteins, and antibodies
07/04/2002WO2001055328A3 Nucleic acids, proteins, and antibodies
07/04/2002WO2001055325A3 Nucleic acids, proteins, and antibodies
07/04/2002WO2001055322A3 Nucleic acids, proteins, and antibodies
07/04/2002WO2001055321A3 Nucleic acids, proteins, and antibodies
07/04/2002WO2001055318A3 Nucleic acids, proteins, and antibodies
07/04/2002WO2001055311A3 Nucleic acids, proteins, and antibodies
07/04/2002WO2001055308A3 Nucleic acids, proteins, and antibodies
07/04/2002WO2001046420A8 Il-17 and il-17r homologous polypeptides and therapeutic uses thereof
07/04/2002WO2001036589A9 Human ex vivo immune system
07/04/2002WO2001032673A9 Sequences encoding human neoplastic marker
07/04/2002WO2000069891A9 Previns as specific inhibitors and therapeutic agents for botulinum toxin b and tetanus neurotoxins
07/04/2002WO2000068242A9 Collagen-binding proteins from enterococcal bacteria
07/04/2002WO2000050081A9 Product and method for treatment of conditions associated with receptor-desensitization
07/04/2002WO2000022430A9 Neisseria genomic sequences and methods of their use
07/04/2002US20020088016 Murine expression of a human IgA lambda locus
07/04/2002US20020086987 Nucleotide sequence coding human protein for use in treatment of osteoporosis and bone disorders
07/04/2002US20020086978 Specific binding agents
07/04/2002US20020086972 Adaptor protein FRS2 and related products and methods
07/04/2002US20020086897 Cytotoxic agents comprising taxanes and their therapeutic use
07/04/2002US20020086848 Associated with Fanconi anaemia (FA), a genetic disease; antibodies, gene therapy
07/04/2002US20020086847 DNA encoding a recombinant antibody molecule end-specific for an amyloid-beta peptide for preventing or inhibiting progression of Alzheimer's Disease
07/04/2002US20020086845 Rat PTTG polypeptide and method for producing it
07/04/2002US20020086841 Naked DNA construct encoding a cytokine selected from macrophage inflammatory protein-1 alpha, monocyte chemoattractant protein 1, and tumor necrosis factor-alpha, linked to a viral transcription control sequence, and carrier
07/04/2002US20020086838 Such as antibodies, proteins, drugs such as spironolactone, imidapril, an angiotensin converting enzyme inhibitor, captopril, enalapril, defibrotide, and angiotensin II receptor antagonist
07/04/2002US20020086831 Methods and use of motoneuronotrophic factors
07/04/2002US20020086830 (HARC), and polynucleotides which encode it; agonists, antibodies, or antagonists specifically binding HARC, and their use in treating diseases associated with expression of HARC
07/04/2002US20020086827 RANK (receptor activator of neurotrophic factor-kappa B) polypeptides; immunoregulatory activity
07/04/2002US20020086826 Antibodies against ligand for receptor activator of NF-kB
07/04/2002US20020086444 Isolated menbrane protein for use in the diagnosis and treatment of alzheimer's disease
07/04/2002US20020086414 Novel ctla4/cd28 ligands and uses therefor
07/04/2002US20020086408 Ubiquitin-like conjugating protein
07/04/2002US20020086403 Polypeptide for use in the treatment and prevention of viral infections and cancer
07/04/2002US20020086385 Nucleotide sequences coding enzyymatic polypeptide for use in prevention of bacterial infection; bactericides
07/04/2002US20020086381 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof
07/04/2002US20020086379 Human membrane-spanning proteins
07/04/2002US20020086360 Polypeptide for use in treatment of congestive heart failure, ischaemic heart defects, arrhytmias, cardioiomyopathy and stroke
07/04/2002US20020086352 Methods for expressing endostatin protein
07/04/2002US20020086335 Nanoparticle for use as biosensors in the detection of nucleic acids, antigens, enzymes and enzyme substrates
07/04/2002US20020086320 Detecting prostate cancer gene in test sample; obtain nucleotide sequence sample, incubate with probe, detect signal for from probes bound to target sequences
07/04/2002US20020086316 Reagents and methods useful for detecting diseases of the prostate
07/04/2002US20020086305 Human c-Maf compositions and methods of use thereof
07/04/2002US20020086301 Reagents and methods useful for detecting diseases of the prostate
07/04/2002US20020086283 Immunogen
07/04/2002US20020086276 Immunotherapeutic methods for extracorporeal modulation of CD36 and its ligands
07/04/2002US20020086034 Compositions and methods for treating viral infections
07/04/2002US20020086030 Preparations and methods for the treatment of t cell mediated diseases
07/04/2002US20020086025 Antibodies that bind to alpha2-antiplasmin crosslinked to fibrin which do not inhibit plasma alpha2-antiplasmin
07/04/2002US20020086024 RatB polypeptides and DNA (RNA) encoding ratB polypeptides producing such polypeptides by recombinant techniques; utilizing ratB polypeptides to screen for antibacterial compounds.
07/04/2002US20020086023 Streptococcal streptolysin S vaccines
07/04/2002US20020086022 A target antigen is mixed with a heterologous antisera specific or cross-reactive to that antigen to produce an inoculant.
07/04/2002US20020086020 Method for improving the half-life of soluble viral receptors on mucosal membranes
07/04/2002US20020086019 Use of polypeptides or nucleic acids for the diagnosis or treatment of skin disorders and wound healing and for the identification of pharmacologically active substances
07/04/2002US20020086014 Human sequence antibody that specifically binds to human CTLA-4; nucleic acid encoding a heavy chain of a human sequence antibody; polyvalent complex; transgenic non-human; treating an autoimmune disease
07/04/2002US20020086011 Administering an effective amount of an OX-2 protein or a nucleic acid encoding an OX-2 protein; use to suppress an immune response and to prevent or treat autoimmune disease, especially arthritis.
07/04/2002US20020086009 Anti-phosphorylated tau protein antibodies and methods for detecting alzheimer`s disease with the use of the same
07/04/2002US20020086008 Human chitinase, its recombinant production, its use for decomposing chitin, its use in therapy or prophylaxis against infection diseases
07/04/2002US20020086007 Angiogenesis-inhibiting peptides and proteins and methods of use
07/04/2002DE10157336A1 Diagnosing pancreatic disorders, particularly pancreatitis, by detecting, in body fluid, proteolysis fragments of exocrine pancreatic proteins
07/04/2002DE10037759A1 Screeningverfahren Screening method
07/04/2002CA2782510A1 Polypeptides
07/04/2002CA2432591A1 A novel human leucine-rich repeat containing protein expressed predominately in bone marrow, hlrrbm1
07/04/2002CA2432380A1 Sugar beet genes involved in stress tolerance
07/04/2002CA2432214A1 Gene involved in apoptosis regulation
07/04/2002CA2432168A1 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
07/04/2002CA2430930A1 Helicobacter proteins, nucleic acids and uses thereof
07/03/2002EP1219710A1 Novel polypeptides and genes encoding the same
07/03/2002EP1219638A2 G-protein coupled receptors having homology to the P2Y purinoreceptor 1 (P2Y1)
07/03/2002EP1219637A1 Polypeptides having a triggering NK activity and biological applications
07/03/2002EP1218538A2 Cancer associated antigens and uses therefor
07/03/2002EP1218520A1 Checkpoint gene associated cell cycle proteins, compositions and methods of use
07/03/2002EP1218519A1 Enzyme which cleaves ester groups and which is derived from thermomonospora fusca
07/03/2002EP1218518A1 Dna polymerase lambda and uses thereof
07/03/2002EP1218515A2 Regulation with binding cassette transporter protein abc1
07/03/2002EP1218511A1 Antimicrobial compositions
07/03/2002EP1218509A2 Fibroblast growth factor-like polypeptides
07/03/2002EP1218507A1 Monoclonal antibody 3f1h10 neutralising vhsv (viral haemorrhagic septicaemia virus)
07/03/2002EP1218506A1 Traf4 associated cell cycle proteins, compositions and methods of use
07/03/2002EP1218505A2 Syk kinase-associated cell cycle proteins, compositions and methods of use
07/03/2002EP1218504A2 Gl50 molecules and uses therefor
07/03/2002EP1218501A1 Creation of variable length and sequence linker regions for dual-domain or multi-domain molecules
07/03/2002EP1218491A1 Dna encoding a human subunit 5-ht3-c of the 5-ht3 serotonin receptor
07/03/2002EP1218414A2 Polypeptides for detection and elimination of ca19-9 antigen positive cells
07/03/2002EP1218413A2 Engineering antibodies that bind irreversibly
07/03/2002EP1218412A2 Human g-protein coupled receptor
07/03/2002EP1218409A2 Factor-h related protein 5 (fhr-5) and antibodies thereto
07/03/2002EP1218408A1 32 human secreted proteins